Stay updated with breaking news from Scientific Statement From. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The application includes data from the Phase 3 registration study of patients with resistant hypertension, where aprocitentan demonstrated a sustained blood pressure reduction over 48 weeks and was well-tolerated Allschwil
On-site care explanations, possible causes, traumatic stress of responders/observers, resources for learning CPR
On-site care explanations, possible causes, traumatic stress of responders/observers, resources for learning CPR
You probably know the usual heart disease causes: too many pounds, lack of exercise, eating too much fat and salt. But much stranger things can also increase the risk of heart disease.
Investegate announcements from Idorsia Pharmaceuticals Ltd, Idorsia submits a New Drug Application to the US FDA for aprocitentan for the treatment of patients with difficult-to-control hypertension